|
1
|
Lopez AD, Mathers CD, Ezzati M, Jamison DT
and Murray CJ: Global and regional burden of disease and risk
factors, 2001: Systematic analysis of population health data.
Lancet. 367:1747–1757. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eum Y and Yim J: Literature and art
therapy in post-stroke psychological disorders. Tohoku J Exp Med.
235:17–23. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hackett ML and Anderson CS: Predictors of
depression after stroke: A systematic review of observational
studies. Stroke. 36:2296–2301. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Evans DL, Charney DS, Lewis L, Golden RN,
Gorman JM, Krishnan KR, Nemeroff CB, Bremner JD, Carney RM, Coyne
JC, et al: Mood disorders in the medically ill: Scientific review
and recommendations. Biol Psychiatry. 58:175–189. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lindén T, Blomstrand C and Skoog I:
Depressive disorders after 20 months in elderly stroke patients: A
case-control study. Stroke. 38:1860–1863. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pan A, Sun Q, Okereke OI, Rexrode KM and
Hu FB: Depression and risk of stroke morbidity and mortality: A
meta-analysis and systematic review. JAMA. 306:1241–1249. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schulz R, Beach SR, Ives DG, Martire LM,
Ariyo AA and Kop WJ: Association between depression and mortality
in older adults: The Cardiovascular Health Study. Arch Intern Med.
160:1761–1768. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pohjasvaara T, Vataja R, Leppävuori A,
Kaste M and Erkinjuntti T: Depression is an independent predictor
of poor long-term functional outcome post-stroke. Eur J Neurol.
8:315–319. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
House A, Knapp P, Bamford J and Vail A:
Mortality at 12 and 24 months after stroke may be associated with
depressive symptoms at 1 month. Stroke. 32:696–701. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu CS, Adibfar A, Herrmann N, Gallagher D
and Lanctot KL: Evidence for inflammation-associated depression.
Current Top Behav Neurosci. 2016. View Article : Google Scholar
|
|
11
|
Connor TJ and Leonard BE: Depression,
stress and immunological activation: The role of cytokines in
depressive disorders. Life Sci. 62:583–606. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dentino AN, Pieper CF, Rao MK, Currie MS,
Harris T, Blazer DG and Cohen HJ: Association of interleukin-6 and
other biologic variables with depression in older people living in
the community. J Am Geriatr Soc. 47:6–11. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tiemeier H, Hofman A, van Tuijl HR,
Kiliaan AJ, Meijer J and Breteler MM: Inflammatory proteins and
depression in the elderly. Epidemiology. 14:103–107. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Berk M, Wadee AA, Kuschke RH and
O'Neill-Kerr A: Acute phase proteins in major depression. J
Psychosom Res. 43:529–534. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kop WJ, Gottdiener JS, Tangen CM, Fried
LP, McBurnie MA, Walston J, Newman A, Hirsch C and Tracy RP:
Inflammation and coagulation factors in persons>65 years of age
with symptoms of depression but without evidence of myocardial
ischemia. Am J Cardiol. 89:419–424. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Penninx BW, Kritchevsky SB, Yaffe K,
Newman AB, Simonsick EM, Rubin S, Ferrucci L, Harris T and Pahor M:
Inflammatory markers and depressed mood in older persons: Results
from the Health, Aging and Body Composition study. Biol Psychiatry.
54:566–572. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ford DE and Erlinger TP: Depression and
C-reactive protein in US adults: Data from the Third National
Health and Nutrition Examination Survey. Arch Intern Med.
164:1010–1014. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Panagiotakos DB, Pitsavos C, Chrysohoou C,
Tsetsekou E, Papageorgiou C, Christodoulou G and Stefanadis C:
ATTICA study: Inflammation, coagulation and depressive
symptomatology in cardiovascular disease-free people; the ATTICA
study. Eur Heart J. 25:492–499. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH
and Sorond F: Relation of C-reactive protein to stroke, cognitive
disorders and depression in the general population: Systematic
review and meta-analysis. Lancet Neurol. 4:371–380. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
ElAli A and Jean LeBlanc N: The role of
monocytes in ischemic stroke pathobiology: New avenues to explore.
Front Aging Neurosci. 8:292016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rothenburg LS, Herrmann N, Swardfager W,
Black SE, Tennen G, Kiss A, Gladstone DJ, Ween J, Snaiderman A and
Lanctôt KL: The relationship between inflammatory markers and post
stroke cognitive impairment. J Geriatr Psychiatry Neurol.
23:199–205. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McKechnie F, Lewis S and Mead G: A pilot
observational study of the association between fatigue after stroke
and C-reactive protein. J R Coll Physicians Edinb. 40:9–12. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Su JA, Chou SY, Tsai CS and Hung TH:
Cytokine changes in the pathophysiology of poststroke depression.
Gen Hosp Psychiatry. 34:35–39. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiménez I, Sobrino T, Rodríguez-Yáñez M,
Pouso M, Cristobo I, Sabucedo M, Blanco M, Castellanos M, Leira R
and Castillo J: High serum levels of leptin are associated with
post-stroke depression. Psychol Med. 39:1201–1209. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang L, Zhang Z, Sun D, Xu Z, Zhang X and
Li L: The serum interleukin-18 is a potential marker for
development of post-stroke depression. Neurol Res. 32:340–346.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brott T, Adams HP Jr, Olinger CP, Marler
JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg
V, et al: Measurements of acute cerebral infarction: A clinical
examination scale. Stroke. 20:864–870. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Steer RA, Clark DA, Beck AT and Ranieri
WF: Common and specific dimensions of self-reported anxiety and
depression: the BDI-II versus the BDI-IA. Behav Res Ther.
37:183–190. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
The World Health Organization Quality of
Life assessment (WHOQOL): Position paper from the World Health
Organization. Soc Sci Med. 41:1403–1409. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schag CC, Heinrich RL and Ganz PA:
Karnofsky performance status revisited: Reliability, validity, and
guidelines. J Clin Oncology. 2:187–193. 1984.
|
|
30
|
Robinson RG and Jorge RE: Post-stroke
depression: A review. Am J Psychiatry. 173:221–231. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Andersen G, Vestergaard K, Riis J and
Lauritzen L: Incidence of post-stroke depression during the first
year in a large unselected stroke population determined using a
valid standardized rating scale. Acta Psychiatr Scand. 90:190–195.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Whyte EM and Mulsant BH: Post stroke
depression: Epidemiology, pathophysiology and biological treatment.
Biol Psychiatry. 52:253–264. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Carota A, Berney A, Aybek S, Iaria G,
Staub F, Ghika-Schmid F, Annable L, Guex P and Bogousslavsky J: A
prospective study of predictors of poststroke depression.
Neurology. 64:428–433. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Karamchandani RR, Vahidy F, Bajgur S, Vu
KY, Choi HA, Hamilton RK, Rahbar MH and Savitz SI: Early depression
screening is feasible in hospitalized stroke patients. PloS One.
10:e01282462015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Miller AH, Maletic V and Raison CL:
Inflammation and its discontents: The role of cytokines in the
pathophysiology of major depression. Biol Psychiatry. 65:732–741.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Miller AH: Norman Cousins Lecture.
Mechanisms of cytokine-induced behavioral changes:
Psychoneuroimmunology at the translational interface. Brain Behav
Immun. 23:149–158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Raison CL, Borisov AS, Majer M, Drake DF,
Pagnoni G, Woolwine BJ, Vogt GJ, Massung B and Miller AH:
Activation of central nervous system inflammatory pathways by
interferon-alpha: Relationship to monoamines and depression. Biol
Psychiatry. 65:296–303. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Capuron L, Neurauter G, Musselman DL,
Lawson DH, Nemeroff CB, Fuchs D and Miller AH:
Interferon-alpha-induced changes in tryptophan metabolism.
Relationship to depression and paroxetine treatment. Biol
Psychiatry. 54:906–914. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kitagami T, Yamada K, Miura H, Hashimoto
R, Nabeshima T and Ohta T: Mechanism of systemically injected
interferon-alpha impeding monoamine biosynthesis in rats: Role of
nitric oxide as a signal crossing the blood-brain barrier. Brain
Res. 978:104–114. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhu CB, Blakely RD and Hewlett WA: The
proinflammatory cytokines interleukin-1beta and tumor necrosis
factor-alpha activate serotonin transporters.
Neuropsychopharmacology. 31:2121–2131. 2006.PubMed/NCBI
|
|
41
|
Besedovsky HO and del Rey A:
Immune-neuro-endocrine interactions: Facts and hypotheses. Endocr
Rev. 17:64–102. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Felger JC, Alagbe O, Hu F, Mook D, Freeman
AA, Sanchez MM, Kalin NH, Ratti E, Nemeroff CB and Miller AH:
Effects of interferon-alpha on rhesus monkeys: A non-human primate
model of cytokine-induced depression. Biol Psychiatry.
62:1324–1333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Capuron L, Raison CL, Musselman DL, Lawson
DH, Nemeroff CB and Miller AH: Association of exaggerated HPA axis
response to the initial injection of interferon-alpha with
development of depression during interferon-alpha therapy. Am J
Psychiatry. 160:1342–1345. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Harbuz MS, Chover-Gonzalez AJ and Jessop
DS: Hypothalamo-pituitary-adrenal axis and chronic immune
activation. Ann N Y Acad Sci. 992:99–106. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Raison CL, Borisov AS, Woolwine BJ,
Massung B, Vogt G and Miller AH: Interferon-alpha effects on
diurnal hypothalamic-pituitary-adrenal axis activity: Relationship
with proinflammatory cytokines and behavior. Mol Psychiatry.
15:535–547. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rich T, Innominato PF, Boerner J, Mormont
MC, Iacobelli S, Baron B, Jasmin C and Lévi F: Elevated serum
cytokines correlated with altered behavior, serum cortisol rhythm
and dampened 24-hour rest-activity patterns in patients with
metastatic colorectal cancer. Clin Cancer Res. 11:1757–1764. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Maes M, Bosmans E, Meltzer HY, Scharpé S
and Suy E: Interleukin-1 beta: A putative mediator of HPA axis
hyperactivity in major depression? Am J Psychiatry. 150:1189–1193.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Vedder H, Schreiber W, Schuld A, Kainz M,
Lauer CJ, Krieg JC, Holsboer F and Pollmächer T: Immune-endocrine
host response to endotoxin in major depression. J Psychiatr Res.
41:280–289. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bernardino L, Agasse F, Silva B, Ferreira
R, Grade S and Malva JO: Tumor necrosis factor-alpha modulates
survival, proliferation and neuronal differentiation in neonatal
subventricular zone cell cultures. Stem Cells. 26:2361–2371. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Goshen I, Kreisel T, Ounallah-Saad H,
Renbaum P, Zalzstein Y, Ben-Hur T, Levy-Lahad E and Yirmiya R: A
dual role for interleukin-1 in hippocampal-dependent memory
processes. Psychoneuroendocrinology. 32:1106–1115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wu CW, Chen YC, Yu L, Chen HI, Jen CJ,
Huang AM, Tsai HJ, Chang YT and Kuo YM: Treadmill exercise
counteracts the suppressive effects of peripheral
lipopolysaccharide on hippocampal neurogenesis and learning and
memory. J Neurochem. 103:2471–2481. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Muir KW, Tyrrell P, Sattar N and Warburton
E: Inflammation and ischaemic stroke. Curr Opin Neurol. 20:334–342.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tarkowski E, Rosengren L, Blomstrand C,
Wikkelsö C, Jensen C, Ekholm S and Tarkowski A: Early intrathecal
production of interleukin-6 predicts the size of brain lesion in
stroke. Stroke. 26:1393–1398. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Pepys MB and Hirschfield GM: C-reactive
protein: A critical update. J Clin Invest. 111:1805–1812. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Burvill PW, Johnson GA, Jamrozik KD,
Anderson CS, Stewart-Wynne EG and Chakera TM: Prevalence of
depression after stroke: The Perth Community Stroke Study. Br J
Psychiatry. 166:320–327. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Aben I, Denollet J, Lousberg R, Verhey F,
Wojciechowski F and Honig A: Personality and vulnerability to
depression in stroke patients: A 1-year prospective follow-up
study. Stroke. 33:2391–2395. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Gillen R, Tennen H, McKee TE, Gernert-Dott
P and Affleck G: Depressive symptoms and history of depression
predict rehabilitation efficiency in stroke patients. Arch Phys Med
Rehab. 82:1645–1649. 2001. View Article : Google Scholar
|
